Navigation Links
First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes

-- Additional Findings Reported on Glucose Homeostasis Effects in Normal and Diabetic Rats --

CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- In a 14-day, Phase IIa study of the safety profile of multiple doses of the investigational compound dapagliflozin, a selective inhibitor of the Sodium-Glucose Transporter 2 (SGLT2) administered alone or concomitantly with metformin in subjects with Type 2 diabetes, no discontinuations due to adverse events and no serious adverse events were reported. The study, presented this week at the annual meeting of the American Diabetes Association, also reported that dapagliflozin, in development by Bristol-Myers Squibb Company and AstraZeneca , statistically significantly reduced fasting serum glucose (FSG) and post challenge glucose excursion in subjects with Type 2 diabetes.

The data were from a double-blind, placebo-controlled, randomized, parallel-group study of 47 subjects with an established diagnosis of Type 2 diabetes (ages 18-77) who were either drug-naive or on a stable dose of metformin for at least 4 weeks prior to randomization with hemoglobin A1C levels between 6 and 10 percent with a FSG of less than or equal to 240 mg/dL. Subjects were randomized to receive either placebo (n=8) or dapagliflozin 5 mg (n=11), 25 mg (n=12), or 100 mg (n=16) once daily for 14 days in addition to their stable metformin dose and/or diet alone in an in-patient clinical research unit. The primary endpoint of the study was to assess both the safety and tolerability profiles of multiple doses of dapagliflozin in subjects with Type 2 diabetes. The secondary endpoints of the study included assessing the fasting serum glucose and post challenge glucose excursion. The presentation, "Dapagliflozin, a Selective Inhibitor of the Sodium-Glucose Uptake Transporter 2 (SGLT2), Reduces Fasting Serum Glucose and Glucose Excursion in Type 2 Diabetes Mellitus Patients Over 14 Days", was presented by Bernard Komoroski, PharmD, Ph.D., Senior Research
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
9. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
Post Your Comments:
(Date:8/29/2014)... 29, 2014 Research and Markets ... Cancer Therapeutics Market & Pipeline Insight 2014" report ... developed to prevent and eradicate the prevalence of cancer ... are confined to low specificity, safety and large number ... for a better solution. It has been discovered that ...
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... PITTSBURGH , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage ... at the Australian and New Zealand Forensic Science ... Forensic Sciences in Adelaide, Australia ... discussion concerning the advancements that hyperspectral imaging can ... Jeffrey Beckstead , Director of Product Development ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... treatment for spine tumorsLAS VEGAS, Feb. 22 For orthopaedic ... is a personal as well as a professional mission. Her ... still remembers the incredible pain her cousin experienced when the ... Dr. Keyak and her colleagues at the University of ...
... and Efficacy Results Support Follow-on NEST-3 TrialCARLSBAD, Calif., ... by PhotoThera, Inc., transcranial laser therapy (TLT) for ... onset demonstrated improved outcomes for patients, but did ... post-hoc analysis in patients who had moderate to ...
Cached Medicine Technology:Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 2Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 3Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009 2
(Date:8/30/2014)... Miami, FL (PRWEB) August 30, 2014 Zensah®, ... new Camo Compression Leg Sleeve . The camo sleeves ... Compression Leg Sleeve collection. The camo line includes classic ... purple and magenta. , Known as tibial stress syndrome, ... side of the lower leg. Swollen and irritated muscles, stress ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Barton Associates, ... locum tenens company , announces a new office ... 2014. Barton Associates is headquartered in Peabody, MA, with ... NH; Austin, TX; and Jupiter, FL. , Barton Associates ... to the physician shortage crisis affecting the United States, ...
(Date:8/30/2014)... 30, 2014 What challenges exist in ... the latest trends, concerns, and considerations? Sports Conflict ... Pendleton recently spoke with Woody Wommack, Southeast Football Recruiting ... issues in football recruiting. Notably, Wommack spoke on ... changes that he thinks are coming as a result ...
(Date:8/30/2014)... 30 August 2014: The first comprehensive ESC Guidelines on ... ESC Congress 2014 by Task Force Chairpersons Professor Raimund ... "2014 ESC Guidelines on the diagnosis and treatment of ... Heart Journal (1) and on the ESC ... published in 2001 but they were restricted to the ...
(Date:8/30/2014)... Saturday 30 August 2014: The therapeutic benefit ... emphasised in the 2014 ESC/EACTS revascularisation guidelines presented ... Professor Stephan Windecker (Switzerland) of the European Society ... of the European Association for Cardio-Thoracic Surgery (EACTS). ... European Heart Journal (1), on the ...
Breaking Medicine News(10 mins):Health News:Camo Compression Leg Sleeves Provide Shin Splint Relief for Runners 2Health News:Barton Associates to Open a New Office Location in Keene, NH 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3Health News:First comprehensive ESC Guidelines on aortic diseases published 2Health News:First comprehensive ESC Guidelines on aortic diseases published 3Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 3
... the Rules and Silences Opposition DebateCHESAPEAKE, Va., April ... Grassfire.org:Fearing they will lack the necessary 60 votes ... rules, House and Senate Democrats last night struck ... of meaningful debate and drops the number of ...
... The YWCA USA co-sponsored another historic first this morning ... Truth in the United States Capitol. An outspoken abolitionist ... to be so honored."This day is long overdue, but ... this courageous American hero," said Lorraine Cole, Ph.D., YWCA ...
... 1 through June 15, nation,s leading drugstore will double ... purchases WOONSOCKET, R.I., April 28 CVS/pharmacy, America,s ... "Double My Bucks!" that offers double Extra Bucks rewards ... 15 at any of CVS/pharmacy,s more than 6,900 locations. ...
... Eppel to Oversee Health Management Division; Kathy Mock ... Blue Cross and Blue Shield of Minnesota (Blue ... part of a realignment among company divisions.Kathy Mock has ... Affairs, giving her senior leadership over Prevention Minnesota, the ...
... efforts ,have run out of steam, expert says, , , TUESDAY, ... of dying prematurely? Don,t smoke and keep a healthy blood ... one in five deaths among U.S. adults, according to new ... be linked with premature death, the magnitude of the effect ...
... new report from Harvard Medical School explains how and why the swine ... infection reaches your community. , ... Boston, MA (Vocus) April 28, 2009 ... the swine flu virus is threatening humans and describes what to do ...
Cached Medicine News:Health News:Fast-Track of Socialized Healthcare Imminent 2Health News:YWCA USA Celebrates Sojourner Truth Memorial in U.S. Capitol 2Health News:CVS/pharmacy Offers Additional Prescription Savings to Help Customers Manage Health Care Costs 2Health News:CVS/pharmacy Offers Additional Prescription Savings to Help Customers Manage Health Care Costs 3Health News:Blue Cross Names Two New Senior Vice Presidents 2Health News:Blue Cross Names Two New Senior Vice Presidents 3Health News:Smoking, Hypertension Each Account for 1 in 5 U.S. Deaths 2Health News:Harvard Medical School Releases Special Health Report on Swine Flu 2
... Lightweight mechanical brace for functional knee ... or LCL instabilities. Unique hinge design ... load on ACL. Does not require ... injured or repaired knee without migration ...
... Orthosis Custom-fitted static-progressive orthosis ... Goniometer version has calibrated ... metal contacts skin. Includes ... bag. One size fits ...
... Polyamide Hinge Wraparound design can ... fit. Multilock polyamide hinge prevents ... extension can be set for ... level. Provides medial/lateral support during ...
... the dynamic way to manage a contracture. ... effective in reducing contractures. Full ROM is ... therapies. Can also be used as a ... and soft tissue contractures. Use where ROM ...
Medicine Products: